Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated

Publication | Open Access

DOI Full Paper Access

Citations

References

2002

Year

Y.-M. Chen, R.-P. Perng, Y.-C. Lee, Jing-Syuan Shih, C.-S. Lee, C.-M. Tsai, Jacqueline Whang‐Peng

Annals of Oncology

Combination ChemotherapyMedicineSimilar EfficacyPharmacologyClinical TrialsBronchial NeoplasmCancer TreatmentOncologyCancer ChemotherapyLung Cancer